Ocular Cicatricial Pemphigoid

Purpose of ReviewThis review offers an informed insight on the pathophysiology of ocular cicatricial pemphigoid in addition to up-to-date recommendations for monitoring and management.Recent FindingsSystemic immunosuppression is required for treatment of ocular cicatricial pemphigoid when there is high suspicion, even in the absence of diagnostic findings on biopsy. New therapeutic modalities continue to emerge and provide promising results. In addition, improved options for adjunctive care are also available.SummaryOcular cicatricial pemphigoid is a systemic illness and a subset of mucous membrane pemphigoid that primarily affects the ocular surface. It involves a progressive and potentially blinding course of disease. Diagnosis remains challenging and mainly depends on clinical suspicion with the aid of laboratory testing. Multiple treatment modalities have emerged for management mainly consisting of systemic immunosuppression for disease control in addition to adjunctive management for alleviating symptoms and preventing complications.